RAINBOW: A global, phase III, randomized, double-blind study of ramucirumab plus paclitaxel versus placebo plus paclitaxel patients with previously treated gastric or gastroesophageal junction (GEJ) adenocarcinoma: Quality-of-life (QoL) results.

被引：1

作者：

Al-Batran, Salah-Eddin

Van Cutsem, Eric

Oh, Sang Cheul

Bodoky, Gyorgy

Shimada, Yasuhiro

Hironaka, Shuichi

Sugimoto, Naotoshi

Lipatov, Oleg N.

Kim, Tae-You

Cunningham, David

Rougier, Philippe

Muro, Kei

Liepa, Astra M.

Ballal, Shaila

Emig, Michael

Ohtsu, Atsushi

Wilke, Hansjochen

机构：

[1] Krankenhaus NW Frankfurt, Frankfurt, Germany

[2] Univ Hosp Gasthuisberg, Leuven, Belgium

[3] Korea Univ, Guro Hosp, Seoul, South Korea

[4] Szent Laszlo Hosp, Budapest, Hungary

[5] Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan

[6] Chiba Canc Ctr, Clin Trial Promot Dept, Chiba 2608717, Japan

[7] Osaka Med Ctr Canc & Cardiovasc Dis, Gastrointestinal Oncol, Osaka, Japan

[8] Bashkortostan Clin Oncol Ctr, Ufa, Russia

[9] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea

[10] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul Natl Univ Hosp, Seoul, South Korea

[11] Royal Marsden Hosp, Sutton, Surrey, England

[12] Univ Paris 05, Hop Europeen Georges Pompidou, Paris, France

[13] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi 464, Japan

[14] Eli Lilly & Co, Indianapolis, IN 46285 USA

[15] ImClone Syst, Bridgewater, MA USA

[16] Eli Lilly & Co, Heidelberg, Germany

[17] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan

[18] Kliniken Essen Mitte Ctr Pallat Care, Essen, Germany

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期

关键词：

D O I：

10.1200/jco.2014.32.15_suppl.4058

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

4058

引用

页数：1